Cetuximab plus XELOX show efficacy against brain metastasis from colorectal cancer: a case report

Brain metastasis (BM) from colorectal cancer (CRC) is rare and associated with poor prognosis. The mainstay of treatment for BM from CRC is radiotherapy, systemic treatment options for CRC can include novel targeted agents, conventional chemotherapy or a combination of both. Nevertheless, the effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahimi, Ahmad KH, Al-Hussaini, Maysa, Laban, Dima Abu, Ammarin, Rula, Wehbeh, Lina, Al-Mousa, Abdelatif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171034/
https://www.ncbi.nlm.nih.gov/pubmed/37129184
http://dx.doi.org/10.2217/cns-2023-0004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171034/
https://www.ncbi.nlm.nih.gov/pubmed/37129184
http://dx.doi.org/10.2217/cns-2023-0004

Ejemplares similares